Bourgogne Fresne

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

A

RECRUITING

This is a Phase II/III Randomized, Open-Label Clinical Study of GB201 in Combination with Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Metastatic Pancreatic Cancer Following Chemotherapy Failure

18+ yearsAll GendersPHASE2PHASE3
38 locations
Bourgogne Fresne Clinical Trials | DecenTrialz